After AdComm rejection, Mallinckrodt’s stannsoporfin gets stiff-armed at FDA.

MLA

“After AdComm Rejection, Mallinckrodt’s Stannsoporfin Gets Stiff-Armed at FDA.” FierceBiotech, Aug. 2018, p. N.PAG. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=131367929&authtype=sso&custid=ns315887.

APA

After AdComm rejection, Mallinckrodt’s stannsoporfin gets stiff-armed at FDA. (2018). FierceBiotech, N.PAG.

Chicago

“After AdComm Rejection, Mallinckrodt’s Stannsoporfin Gets Stiff-Armed at FDA.” 2018. FierceBiotech, August, N.PAG. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=131367929&authtype=sso&custid=ns315887.